Publication | Open Access

A Phase I randomized clinical trial testing the safety, tolerability and preliminary pharmacokinetics of the mGluR5 negative allosteric modulator GET 73 following single and repeated doses in healthy volunteers

Preliminary PharmacokineticsMedicineHealthy VolunteersNeuropharmacologyClinical PharmacologyPharmacotherapyPharmacologyPharmacokineticsDrug DiscoveryTranslational Pharmacology